Editor's Note Multimodal analgesia with minimal opiates improved pain control and significantly decreased opiate use and opiate-related adverse effects after discharge from elective total hip replacement surgery, finds this study. The 235 patients analyzed received one of three discharge pain regimens: Group A: scheduled-dose multimodal analgesia (ie, acetaminophen, meloxicam, gabapentin)…

Read More

Editor's Note The Joint Commission announced June 5 that beginning January 1, 2020, accredited office-based surgery practices that provide fluoroscopy services will be required to comply with element of performance (EP) 17 of Environment of Care (EC) standard EC.02.02.01: The practice manages risks related to hazardous materials and waste. This…

Read More

Editor's Note The Food & Drug Administration’s General and Plastic Surgery Devices Advisory Committee on May 30 recommended that surgical staplers be reclassified from Class I to Class II devices. This would add premarket review and special controls to the devices. The Committee said Class II regulation would offer a…

Read More

Editor's Note Stratification of hospitals in Medicare’s Hospital Readmission Reduction Program (HRRP) was associated with a significant shift in hospital penalties for excess readmissions, this study finds. Beginning in FY 2019, Medicare is stratifying hospitals into five peer groups based on the proportions of each hospital’s patient population that is…

Read More

Editor's Note The Pain Management Best Practices Inter-Agency Task force, a Health and Human Services (HHA) federal advisory committee on May 30 released its final report. The report calls for a balanced, individualized, patient-centered approach to pain management and underscores the need to address stigma, risk assessment, access to care,…

Read More

Editor's Note Patients on an opioid-sparing postoperative pain management pathway reported minimal or no opioid use and high satisfaction and pain control in this study. A total of 190 patients having one of six different procedures participated in the pathway and were advised to use acetaminophen and ibuprofen every 6…

Read More

Editor's Note The Food & Drug Administration on May 30 identified the recall by Terumo Medical Corporation (Somerset, New Jersey) of its SOLOPATH Balloon Expandable TransFemoral System and Re-Collapsible Balloon Access System as Class I, the most serious. The recall was initiated because the tip could dislodge from the outer…

Read More

Editor's Note The Joint Commission on May 29 announced performance measures for two newly developed advanced Disease-Specific Care Certification programs−Acute Heart Attack Ready and Primary Heart Attack Center. The measures will go into effect July 1, 2019, for critical access hospitals and hospitals (including freestanding emergency departments) pursuing these certifications.…

Read More

Editor's Note The Food & Drug Administration (FDA) on May 28 announced the recall by Heritage Pharmaceuticals Inc (East Brunswick, New Jersey) of Amikacin Sulfate Injection, USP 1 gm/4 mL (250 mg/mL), Lot: VEAC025, Expiry Date: October 2019; and Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL), Lot: VPCA172,…

Read More

Editor's Note In this study, postoperative delirium significantly increased the risk of postoperative cognitive dysfunction in older adults at 1 month after surgery, but there was no association at 2 and 6 months. Of 560 patients analyzed, 24% developed delirium during hospitalization. At 1 month after surgery, 47% had not…

Read More